Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged-release Tacrolimus in Stable Liver Transplant Recipients
NCT06147648Phase 4Not yet recruiting
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- Dec 2023
- Primary completion
- Jul 2025
- Modality
- RNA-Targeting Small Molecules
01
Overview
A Phase 4 trial of tacrolimus in Liver transplant rejection, sponsored by Beijing Tsinghua Changgung Hospital. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT06147648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06147648.